BRCA2 and cancer: Following mutation negative findings due to a targeted mutation screen of the most common BRCA1/BRCA2 mutations found in French Canadians, a comprehensive commercial-based mutation analysis performed in the hereditary cancer clinic revealed that patient 4485 harbored the BRCA1:IVS14-1G>T (c.4485-1 G>T) mutation.